HIGHLIGHTS
- who: Jinfeng Cui from the Clinical Medical College, Shandong University, Jinan, China, Department of, Shandong Cancer Hospital have published the research: The Value of Radiotherapy for Advanced Non-Small Cell Lung Cancer With Oncogene Driver-Mutation, in the Journal: (JOURNAL)
- how: The endpoint was mortality rate among the treatments the results showed that the mortality rates of the groups 1 and 2 were 40.25% and 31.19% respectively (p=0.0042). Gadgeel S et_al conducted a phase III ALEX study in patients with treatment-nau00efve stage IV ALK+ NSCLC the result showed that compared . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.